Mahsa Shahriari

Mahsa Shahriari

Auto-generated profile, based on publicly available information

Mahsa Shahriari

Pharmaceutical Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran; Department of Pharmaceutical Biotechnology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2019 in Journal of Controlled Release
Verified
Journal Article
Closed access
MSMahsa Shahriari
Mahsa Shahriari
MZMahsa Zahiri
Mahsa Zahiri
KAKhalil Abnous
Khalil Abnous
STSeyed Mohammad Taghdisi
Seyed Mohammad Taghdisi
MRMohammad Ramezani
Mohammad Ramezani
MAMona Alibolandi
Mona Alibolandi

1 December 2019 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
MSMahsa Shahriari
Mahsa Shahriari
STSeyed Mohammad Taghdisi
Seyed Mohammad Taghdisi
KAKhalil Abnous
Khalil Abnous
MRMohammad Ramezani
Mohammad Ramezani
MAMona Alibolandi
Mona Alibolandi

2 October 2020 in Biomaterials Science
Verified
Journal Article
Closed access
PDF file
MSMahsa Shahriari
Mahsa Shahriari
VTVladimir P. Torchilin
Vladimir P. Torchilin
STSeyed Mohammad Taghdisi
Seyed Mohammad Taghdisi
KAKhalil Abnous
Khalil Abnous
MRMohammad Ramezani
Mohammad Ramezani
MAMona Alibolandi
Mona Alibolandi
In the current review, we summarized the polymer and peptide-based schizophrenic copolymers which could form micellar and vesicular (polymersome) systems providing novel structures with beneficial applications.

1 January 2019
Verified
Book Chapter
Closed access
MAMona Alibolandi
Mona Alibolandi
MSMahsa Shahriari
Mahsa Shahriari
MRMohammad Ramezani
Mohammad Ramezani

15 February 2022 in Journal of Drug Delivery Science and Technology
Verified
Journal Article
Closed access
STSahar Taghavi
Sahar Taghavi
MSMahsa Shahriari
Mahsa Shahriari
KAKhalil Abnous
Khalil Abnous
STSeyed Mohammad Taghdisi
Seyed Mohammad Taghdisi
MAMona Alibolandi
Mona Alibolandi
MRMohammad Ramezani
Mohammad Ramezani

4 June 2026 in Turkish Journal of Fisheries and Aquatic Sciences
Verified
Journal Article
Closed access
HAHussein Mahdi Kareem Al-Mohammad
Hussein Mahdi Kareem Al-Mohammad
DEDelaram Eslimi Esfahani
Delaram Eslimi Esfahani
EAEhsan Ahmadifar
Ehsan Ahmadifar
SMSedigheh Mohammadzadeh
Sedigheh Mohammadzadeh
MAMehdi Ahmadifar
Mehdi Ahmadifar
MAMohsen Abdel-Tawwab
Mohsen Abdel-Tawwab
In the present study, we evaluated the changes in gonad-somatic index (GSI), as well as stress and reproductive-related gene expression in female zebrafish (Danio rerio) exposed to environmentally relevant and pharmacological concentrations of 17alpha-ethinylestradiol (EE2; 0.5-500 ng/L) for 21 days. Although the endocrine-disrupting effects of EE2 are well-documented, there remains a gap in understanding its concurrent impact on both reproductive and stress axes, particularly at pharmacological doses. Therefore, this study aimed to fill this gap by simultaneously assessing steroidogenesis, stress responses, and their molecular regulators. Fish mortality was significantly higher at the two highest concentrations (50 and 500 ng EE2/L), while no mortality occurred at lower concentrations. A significant increase in whole-body vitellogenin (Vtg) and mRNA level of Vtg1 was observed at concentrations of 5 ng/L and above, with no significant differences among these groups. In contrast, the levels of sex steroids (17beta-estradiol and testosterone), as well as the expression of reproductive-related genes (StAR, cyp19a1), significantly decreased at 50 and 500 ng/L. Additionally, cortisol levels and glucocorticoid receptor (GR) gene expression were significantly reduced at these same concentrations. In conclusion, this study provides novel evidence that EE2, particularly at pharmacological doses of 50 and 500 ng/L, simultaneously disrupts steroidogenesis and impairs the stress axis in female zebrafish, likely through interference with the expression of key genes governing sex steroid synthesis and stress regulation.